Jenette Creaney

42.6k total citations · 1 hit paper
115 papers, 4.2k citations indexed

About

Jenette Creaney is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Jenette Creaney has authored 115 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Jenette Creaney's work include Occupational and environmental lung diseases (87 papers), Pleural and Pulmonary Diseases (58 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers). Jenette Creaney is often cited by papers focused on Occupational and environmental lung diseases (87 papers), Pleural and Pulmonary Diseases (58 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (34 papers). Jenette Creaney collaborates with scholars based in Australia, United States and Canada. Jenette Creaney's co-authors include Bruce Robinson, B. W. Robinson, Arthur W. Musk, Anna K. Nowak, Richard Lake, Ian M. Dick, Nicholas de Klerk, Amanda Segal, Steven J. Skates and Ingegerd Hellström and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Jenette Creaney

113 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

2011 512 citations Jenette Creaney, Richard Lake et al. profile →

Peers

Countries citing papers authored by Jenette Creaney

Since Specialization

Citations

This map shows the geographic impact of Jenette Creaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenette Creaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenette Creaney more than expected).

Fields of papers citing papers by Jenette Creaney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenette Creaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenette Creaney. The network helps show where Jenette Creaney may publish in the future.

Co-authorship network of co-authors of Jenette Creaney

This figure shows the co-authorship network connecting the top 25 collaborators of Jenette Creaney. A scholar is included among the top collaborators of Jenette Creaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenette Creaney. Jenette Creaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study 2022 ·Journal of Thoracic Oncology ·(unknown), Vasiliki Panou, (unknown), Christos Meristoudis, (unknown), (unknown), Gary Lee, Ian M. Dick, (unknown), (unknown), (unknown), Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe	33
2	A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers 2021 ·Expert Review of Anticancer Therapy ·Alistair Cook, Alison M. McDonnell, Michael Millward, Jenette Creaney, Arman Hasani, Michelle McMullen, Tarek Meniawy, Bruce Robinson, Richard Lake, Anna K. Nowak	0
3	Hyaluronic acid in viscous malignant mesothelioma pleural effusion 2020 ·Australasian Journal of Paramedicine ·(unknown), Deirdre Fitzgerald, (unknown), Jenette Creaney, Gary Lee	4
4	A phase II trial of single oral FGF inhibitor, AZD4547, as second or third line therapy in malignant pleural mesothelioma 2019 ·Lung Cancer ·Wei‐Sen Lam, Jenette Creaney, Fred K. Chen, Wee Loong Chin, Sanjeevan Muruganandan, (unknown), Mary S. Attia, Catherine Read, Kevin Murray, Michael Millward, (unknown), Aron Chakera, Gary Lee, Anna K. Nowak	27
5	MA23.01 Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study 2019 ·Journal of Thoracic Oncology ·(unknown), Anna K. Nowak, Fred K. Chen, Sanjeevan Muruganandan, (unknown), Melvin Chin, Michael Millward, Catherine Read, Kevin Murray, Jenette Creaney, Gary Lee	1
6	Simplified Criteria Using Pleural Fluid Cholesterol and Lactate Dehydrogenase to Distinguish between Exudative and Transudative Pleural Effusions 2019 ·Respiration ·(unknown), Rajesh Thomas, Sébastien Nguyen, Yves Lacasse, (unknown), Jenette Creaney, Sanjeevan Muruganandan, Simon Martel, Gary Lee, Antoine Delage	11
7	P2.06-026 A Phase II Trial of the Oral FGF Receptor Inhibitor AZD4547 as 2nd or 3rd Line Therapy in Malignant Pleural Mesothelioma - Trial in Progress 2017 ·Journal of Thoracic Oncology ·Wei‐Sen Lam, Gary Lee, Jenette Creaney, Sanjeevan Muruganandan, Michael Millward, Catherine Read, Anna K. Nowak	2
8	A Novel Clinical Prediction Model for Prognosis in Malignant Pleural Mesothelioma Using Decision Tree Analysis 2016 ·Journal of Thoracic Oncology ·Fraser Brims, Tarek Meniawy, (unknown), Duneesha de Fonseka, Amanda Segal, Jenette Creaney, Nick Maskell, Richard Lake, Nicholas de Klerk, Anna K. Nowak	102
9	Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma 2015 ·Current Opinion in Pulmonary Medicine ·Jenette Creaney, Ian M. Dick, B. W. Robinson	23
10	Increased circulating miR-625-3p 2012 ·Murdoch Research Repository (Murdoch University) ·Michaela B. Kirschner, Yuen Yee Cheng, (unknown), Steven Kao, Jenette Creaney, J. James Edelman, Nicola J. Armstrong, Michael P. Vallely, (unknown), (unknown), Brian C. McCaughan, Sonja Klebe, Steven E. Mutsaers, Nico van Zandwijk, Glen Reid	1
11	Increased Circulating miR-625-3p: A Potential Biomarker for Patients With Malignant Pleural Mesothelioma 2012 ·Journal of Thoracic Oncology ·Michaela B. Kirschner, Yuen Yee Cheng, (unknown), Steven Kao, Jenette Creaney, J. James Edelman, Nicola J. Armstrong, Michael P. Vallely, Arthur W. Musk, B. W. Robinson, Brian C. McCaughan, Sonja Klebe, Steven E. Mutsaers, Nico van Zandwijk, Glen Reid	94
12	A Phase II Study of Intermittent Sunitinib Malate as Second-Line Therapy in Progressive Malignant Pleural Mesothelioma 2012 ·Journal of Thoracic Oncology ·Anna K. Nowak, Michael Millward, Jenette Creaney, Roslyn J. Francis, Ian M. Dick, Arman Hasani, (unknown), Amanda Segal, Arthur W. Musk, Michael Byrne	73
13	A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20 year audit 2012 ·Pathology ·Amanda Segal, Gregory F. Sterrett, Felicity Frost, Κ.B. Shilkin, Nola Olsen, Arthur W. Musk, Anna K. Nowak, B. W. Robinson, Jenette Creaney	86
14	Mesothelin and kidney function—Analysis of relationship and implications for mesothelioma screening 2011 ·Lung Cancer ·Neil Boudville, Rohan Paul, B. W. Robinson, Jenette Creaney	23
15	Sensitivity of Urinary Mesothelin in Patients with Malignant Mesothelioma 2010 ·Journal of Thoracic Oncology ·Jenette Creaney, Arthur W. Musk, B. W. Robinson	11
16	Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control study 2008 ·Lung Cancer ·Oluf Dimitri Røe, Jenette Creaney, Steinar Lundgren, Erik G. Larsson, (unknown), Paolo Boffetta, Tom Ivar Lund Nilsen, Bruce Robinson, Kristina Kjærheim	45
17	Soluble Mesothelin-related Protein in an Asbestos-exposed Population: The Dust Diseases Board Cohort Study 2008 ·American Journal of Respiratory and Critical Care Medicine ·Eun‐Kee Park, Alessandra Sandrini, Deborah Yates, Jenette Creaney, B. W. Robinson, Paul S. Thomas, Anthony Johnson	74
18	Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma 2007 ·CHEST Journal ·Jenette Creaney, Ivonne van Bruggen, (unknown), Amanda Segal, Arthur W. Musk, Nicholas de Klerk, Nora Horick, Steven J. Skates, B. W. Robinson	74
19	A Molecular Diagnostic Test for Distinguishing Lung Adenocarcinoma from Malignant Mesothelioma Using Cells Collected from Pleural Effusions 2006 ·Clinical Cancer Research ·Andrew Holloway, Dileepa Diyagama, Ken Opeskin, Jenette Creaney, B. W. Robinson, Richard Lake, David D.L. Bowtell	29
20	Attempted immunisation of sheep against Fasciola hepatica using γ-irradiated metacercariae 1995 ·International Journal for Parasitology ·Jenette Creaney, Terry W. Spithill, (unknown), Lachlan R. Wilson, R.M. Sandeman, Jim C. Parsons	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact